Neurochlore

These two videos highlight the groundbreaking work of Professor Ben-Ari and the Neurochlore startup in advancing treatments for autism, glioblastoma, and neurological disorders. The first video showcases pioneering research into autism, including the use of machine learning to identify responsive subpopulations and the development of next-generation NKCC1 inhibitors to alleviate autism symptoms and seizures. The second video focuses on innovative NKCC1 inhibitors that reduce tumor migration and trigger apoptosis, offering new hope for glioblastoma patients. Together, these videos demonstrate Neurochlore's commitment to revolutionizing therapeutic strategies and transforming lives worldwide.